HOME >> MEDICINE >> NEWS
Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimer's Jigsaw

(Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial)

Acetylcholinesterase inhibitors, such as tacrine and donepezil, which have been designed to boost the apparent chemical deficiency in the brain caused by Alzheimer's disease, are the most successful treatments to date. In this week's BMJ Professor Michael Rsler from Psychiatrische Universittsklinik, Germany and colleagues report the finding of the first large trial of another acetylcholinesterase inhibitor used by patients suffering from Alzheimer's, in a mainly European population.

The authors' six month trial involved the drug rivastigmine and they found that it was effective in treating some of the symptoms of patients with mild or moderate Alzheimer's disease. The research team also discovered that the effects of rivastigmine seem to be dose dependent - those patients receiving a higher dose of the drug showed clinically relevant (and statistically significant) improvements.

Rsler et al draw attention to the gastrointestinal side-effects experienced by some patients (27 per cent of those taking the higher dose of rivastigmine discontinued treatment owing to adverse effects), but report that these effects were mild and short lived and only occurred after the dosage had been increased.

In an accompanying commentary, Dr Tony Bayer from the University of Wales College of Medicine writes that the research by Rsler et al provides another piece in the Alzheimer's jigsaw, but also reports some of the shortcomings of their study. Bayer says that the patients who participated in the trial were not typical of those generally seen by psychiatrists and geriatricians and he says that the absence of measures of the neuropsychiatric effect of the drug is "unfortunate". Bayer also reports that the study "....tells us nothing about the long term impact of acetylcholinesterase inhibitor treatment or the considerable human
'"/>

Contact: Jill Shepherd
jshepherd@bma.org.uk
44-171-383-6529
BMJ-British Medical Journal
5-Mar-1999


Page: 1 2

Related medicine news :

1. Inhibitors prevent aggresome formation associated with some forms of ALS
2. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine
3. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report
4. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
5. Answers To Access, Adherence And Tolerance Of Protease Inhibitors
6. ACE-Inhibitors Score High In Reducing Heart Attack Deaths
7. Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors
8. Another look finds promising proteomics test is not biologically plausible
9. Another step towards understanding the causes of narcolepsy
10. Another US airport travel hazard dirty hands
11. Another cold? The best advice is still plenty of rest and fluids

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... Modere (the “Company”), ... with a presence worldwide, today announced that it built on 2017’s growth momentum, ... grew by double-digits in North America, by more than five times in Europe ...
(Date:1/14/2019)... ... January 14, 2019 , ... The ... availability of VARIZIG® (Varicella Zoster Immune Globulin [Human]) for post-exposure prophylaxis of ... the update, the CDC notes that VARIZIG is commercially available from a broad ...
(Date:1/14/2019)... ... 2019 , ... Dr. Kaveh Kanani D.D.S . is the head of Around the Corner ... general dentist has recently unveiled an inventive method of inserting dental implants. , ... is missing for an extended period of time, the jawbone that used to hold the ...
(Date:1/13/2019)... ... January 12, 2019 , ... On December 13th, The Pennsylvania ... hosted a continuing education (CEU) event entitled, Can You Hear Me Now? Creating ... a series of talks to help develop and cultivate the relationship between mentors ...
(Date:1/11/2019)... ... 11, 2019 , ... In Partnership with the Smiles for Everyone Foundation ... at its Burleson, TX office on February 9. , Dental services provided ... and extractions . For more information, please visit the Monarch Dental website ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... (PRWEB) , ... January 10, 2019 , ... ... wellness company providing nutrition and lifestyle solutions, will crown the U.S. winner of ... Period’s 15 finalists include: Andrea Carrara of Palm Beach, Florida; Barbara Lingle of ...
(Date:1/8/2019)... , ... January 08, 2019 , ... ... been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. ... System and demonstrated a commitment to exemplary care for men suffering from symptoms ...
(Date:1/8/2019)... ... January 08, 2019 , ... Date aired: August 13th, 2018 , Guest: ... excessive evaporation of the tear film, which is naturally 99 percent water, and it ... says water researcher Sharon Kleyne, host of the internationally syndicated radio program, The Sharon ...
Breaking Medicine Technology:
Cached News: